2026 NPPES data General Practice Physician NPI 1366634065 M.D.
Verify on CMS →

Amalys Montanez-Leduc, M.D.

General Practice Physician in Humacao, Puerto Rico.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 16,725 in General Practice Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
936
Medicare Part D claims · 47 beneficiaries · General Practice Physician avg: 3K
Generic prescribing
90%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Amalys Montanez-Leduc, M.D. filed 936 Medicare Part D claims in 2023 as a General Practice Physician in Humacao, Puerto Rico, prescribing 90% generic.

936
Part D claims, 2023
90%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Amalys Montanez-Leduc, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

936 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Amalys Montanez-Leduc, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Amalys Montanez-Leduc, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/16/2007

NPI 1366634065

Primary specialty

General Practice Physician

Mid-sized

16,725 US NPIs in this specialty

Medicare Part D claims

936 67% vs specialty avg

2023 prescription claims

Specialty avg: 2,872

Specialty distribution in Puerto Rico

How General Practice Physician compares to other specialties among Puerto Rico providers

Puerto Rico providers
General Practice Physician10%Student in an Organized Heal…8.9%Pharmacist8%Pharmacy Technician5.1%Clinical Psychologist4.7%Clinical Social Worker4.2%
Largest specialties in Puerto Rico (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for General Practice Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Amalys Montanez-Leduc, M.D. appears in the CMS NPPES registry as a General Practice Physician provider holding M.D. credentials at 7 CALLE PADRE RIVERA W, Humacao, PR, 00791, with a listed phone of (787) 718-9951. NPI 1366634065 was issued on 08/16/2007.

Medicare Part D records for calendar year 2023 show 936 prescription claims written by this provider, covering 47 Medicare beneficiaries and totaling roughly $27K in drug spend, split 7% brand-name and 90% generic by claim count.

General Practice Physician is a mid-sized specialty nationwide, with 16,725 enrolled providers across 56 states and an average of 2,872 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7 CALLE PADRE RIVERA W
Humacao, PR 00791

Provider Details

NPI 1366634065
Specialty General Practice Physician
Credentials M.D.
Gender Female
NPI Issued 08/16/2007

Brand vs generic prescribing mix · Generic-heavy

Amalys Montanez-Leduc, M.D. - brand share 7.0%
General Practice Physician average

7% brand-name claims vs 90% generic, on 936 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

936
Total Claims
$27K
Total Drug Cost
47
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,290
Total Day Supply
36,392
Brand vs Generic
7% brand / 90% generic
Brand Drug Cost
$15K
Generic Drug Cost
$12K
Antibiotic Claims
15

Patient Demographics

Average Patient Age
68.7 years
Avg HCC Risk Score
1.44
Gender Split
60% female / 40% male
Age Distribution
<65: 12, 65-74: 21, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Amalys Montanez-Leduc, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
94
Gabapentin
90
Metformin Hcl
63
Lisinopril
59
Famotidine
57
Simvastatin
47
Allopurinol
41
Levothyroxine Sodium
32
Tamsulosin Hcl
30
Amlodipine Besylate
27

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

General Practice Physician Overview

How Amalys Montanez-Leduc, M.D. fits within the General Practice Physician landscape nationally.

16,725
General Practice Physician Providers in US
56
States with General Practice Physician
2,872
Avg Claims per Provider

Amalys Montanez-Leduc, M.D.'s 936 claims are below the specialty average of 2,872.

Nearby General Practice Physician Providers in Puerto Rico

Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as Montanez-Leduc.

Compare General Practice Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Puerto Rico medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby General Practice Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Amalys Montanez-Leduc, M.D.'s specialty?
Amalys Montanez-Leduc, M.D. specializes in General Practice Physician and practices in Humacao, Puerto Rico. Credentials: M.D..
How much does Amalys Montanez-Leduc, M.D. prescribe under Medicare Part D?
In 2023, Amalys Montanez-Leduc, M.D. wrote 936 Medicare Part D claims totaling $27K in drug costs for 47 beneficiaries.
Where is Amalys Montanez-Leduc, M.D. located?
Amalys Montanez-Leduc, M.D. is located at 7 CALLE PADRE RIVERA W, Humacao, PR, 00791. Phone: (787) 718-9951.
What is Amalys Montanez-Leduc, M.D.'s NPI number?
Amalys Montanez-Leduc, M.D.'s National Provider Identifier (NPI) is 1366634065, issued on 08/16/2007.
Does Amalys Montanez-Leduc, M.D. prescribe more brand-name or generic drugs?
Amalys Montanez-Leduc, M.D.'s prescribing is 7% brand-name and 90% generic drugs by claim count, with $15K in brand drug costs.
How many General Practice Physician providers are there in the US?
There are 16,725 General Practice Physician providers across 56 states in the US. The average General Practice Physician provider writes 2,872 Medicare Part D claims per year.
What drugs does Amalys Montanez-Leduc, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Amalys Montanez-Leduc, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Gabapentin, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Amalys Montanez-Leduc, M.D. accept Medicare?
Amalys Montanez-Leduc, M.D. appears in CMS Medicare data with 936 Part D claims and 47 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Amalys Montanez-Leduc, M.D.'s credentials?
Amalys Montanez-Leduc, M.D.'s NPI is 1366634065 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.